Impact of Head and Neck Cancer Center Accreditation on Patient Survival Outcomes - Top-Institutions - MDSpire

Impact of Head and Neck Cancer Center Accreditation on Patient Survival Outcomes

  • By

  • Olaf Schoffer

  • Max Kemper

  • Michael Gerken

  • Veronika Bierbaum

  • Christoph Bobeth

  • Martin Rößler

  • Patrik Dröge

  • Thomas Ruhnke

  • Christian Günster

  • Kees Kleihues-van Tol

  • Chia-Jung Busch

  • Monika Klinkhammer-Schalke

  • Jochen Schmitt

  • January 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Head and Neck Oncology
    • Radiation Oncology
    • Surgical Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Head and Neck Oncology
    • Surgical Oncology
    • Medical Oncology

  • #3

    Dana-Farber/Brigham and Women’s Cancer Center
    Dana-Farber/Brigham and Women’s Cancer Center

    Boston, MA

    Key Differentiators

    • Head and Neck Oncology
    • Radiation Oncology
    • Medical Oncology

  • #4

    University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center
    University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center

    Pittsburgh, PA

    Key Differentiators

    • Head and Neck Oncology
    • Surgical Oncology
    • Radiation Oncology

  • #5

    Charité – Universitätsmedizin Berlin
    Charité – Universitätsmedizin Berlin

    Berlin, Germany

    Key Differentiators

    • Head and Neck Oncology
    • Surgical Oncology
    • Radiation Oncology

Original Source(s)

Impact of Head and Neck Cancer Center Accreditation on Patient Survival Outcomes

  • by Olaf Schoffer, Max Kemper, Michael Gerken, Veronika Bierbaum, Christoph Bobeth, Martin Rößler, Patrik Dröge, Thomas Ruhnke, Christian Günster, Kees Kleihues-van Tol, Chia-Jung Busch, Monika Klinkhammer-Schalke, Jochen Schmitt

  • January 26, 2026

Related Content

Correction: Overcoming chemoresistance in esophageal cancer with synergistic strategies

2026 ASCO Bladder Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates

  • July 2, 2026

  • 1 min
Immunoglobulin G in aging and cancer